Published in Am J Med on December 19, 2005
Short-term (1-2 mo) hormone therapy cessation before mammography. Menopause (2009) 1.50
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. Int J Womens Health (2010) 0.93
Managing the menopause. BMJ (2007) 0.92
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy. Obstet Gynecol Int (2013) 0.89
Perceived control and hot flashes in treatment-seeking breast cancer survivors and menopausal women. Cancer Nurs (2012) 0.87
HIV-positive mothers with late adolescent/early adult children: "empty nest" concerns. Health Care Women Int (2012) 0.84
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study. Br J Clin Pharmacol (2011) 0.79
A prospective study of hormone therapy and depression in community-dwelling elderly women: the Three City Study. J Clin Psychiatry (2010) 0.78
Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women. PLoS One (2014) 0.78
Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy. Menopause (2012) 0.77
Perspectives on menopause and women with HIV. Int J Womens Health (2016) 0.75
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81
Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med (2008) 1.70
USPSTF recommendations for STI screening. Am Fam Physician (2008) 1.68
HPV vaccination--more answers, more questions. N Engl J Med (2007) 1.64
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause (2009) 1.63
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol (2012) 1.52
Evidence-based medicine versus liquid-based cytology. Obstet Gynecol (2008) 1.43
Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev (2011) 1.33
Persistent hot flushes in older postmenopausal women. Arch Intern Med (2008) 1.28
Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause (2009) 1.23
Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol (2005) 1.18
Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med (2013) 1.17
Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2007) 1.10
Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat (2012) 1.10
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol (2003) 1.07
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01
Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol (2009) 0.97
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns (2012) 0.87
Defining competencies for education in health care value: recommendations from the University of California, San Francisco Center for Healthcare Value Training Initiative. Acad Med (2015) 0.86
Cervical cancer screening continues to limit provision of contraception. Contraception (2005) 0.86
Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med (2012) 0.81
Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later. Ann Intern Med (2008) 0.81
Treatment patterns for cervical carcinoma in situ in Michigan, 1998-2003. J Registry Manag (2013) 0.81
Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol (2008) 0.80
New guidelines: it's complicated. Obstet Gynecol (2013) 0.80
Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol (2010) 0.79
Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol (2011) 0.78
Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? J Low Genit Tract Dis (2013) 0.78
Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages. Ann Intern Med (2007) 0.77
Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues (2013) 0.77
Cervical cancer screening among women without a cervix. JAMA (2004) 0.75
Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet Gynecol (2009) 0.75
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol (2011) 0.75
Screening pelvic examinations: right, wrong, or rite? Ann Intern Med (2014) 0.75
The new mammographic screening guidelines: what were they thinking? Obstet Gynecol (2010) 0.75
Papanicolaou testing: when does more become less? Am J Med (2005) 0.75
Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.75
Testing for human papillomavirus in women with abnormal pap smear results. JAMA (2002) 0.75
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol (2017) 0.75
Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening. Acta Cytol (2003) 0.75
Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis (2006) 0.75